Wet age related macular degeneration
Clinical trials for Wet age related macular degeneration explained in plain language.
Never miss a new study
Get alerted when new Wet age related macular degeneration trials appear
Sign up with your email to follow new studies for Wet age related macular degeneration, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drug goes Head-to-Head with standard treatment for wet AMD
Disease control Not yet recruitingResearchers are testing an experimental drug called OLN324 against ranibizumab, a standard treatment for wet age-related macular degeneration (nAMD). The trial enrolls about 400 adults aged 50 and older who have not yet received treatment for active wet AMD in the study eye. Part…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase 3 • Sponsor: Ollin Biosciences, Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New eye drug goes Head-to-Head with standard care for wet AMD
Disease control Not yet recruitingResearchers are testing an experimental drug called OLN324 against the standard treatment, aflibercept, in adults with wet age-related macular degeneration. About 500 people aged 50 and older who have not yet received treatment for this condition will take part. Both drugs are gi…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase 3 • Sponsor: Ollin Biosciences, Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
One-Shot gene therapy aims to end monthly eye injections for wet AMD
Disease control Not yet recruitingThis early-stage trial tests EXG202, a gene therapy given as a single injection into the eye for people with wet age-related macular degeneration (AMD). The goal is to see if it is safe and can produce a protein that blocks abnormal blood vessel growth long-term, potentially redu…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase 1/2 • Sponsor: Guangzhou Jiayin Biotech Ltd • Aim: Disease control
Last updated Jun 26, 2026 17:51 UTC
-
Could eye drops replace injections for a leading cause of blindness?
Knowledge-focused Not yet recruitingThis early-stage trial is evaluating the safety, tolerability, and how the body absorbs PAN-90806, an experimental eye drop being developed for wet age-related macular degeneration (AMD), a leading cause of vision loss. Healthy adults aged 18 to 50 will receive either PAN-90806 o…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase 1 • Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Elderly AMD patients to test Easy-to-Use home vision tracker
Knowledge-focused Not yet recruitingThis study aims to see if elderly patients with age-related macular degeneration (AMD) find a new web-based eye-tracking system easy and acceptable to use at home. The system is designed to help patients monitor their vision without frequent clinic visits. Thirty patients aged 55…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Sponsor: Tan Tock Seng Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC